BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

BXPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

BXPHARMA 20-Jan-2020

The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2019 to the respective shareholders' Bank Accounts through BEFTN system.

BXPHARMA 25-Nov-2019

Trading of the Shares of the Company will resume on 26.11.2019 after record date.

BXPHARMA 24-Nov-2019

Trading of the shares of the Company will remain suspended on record date i.e., 25.11.2019.

BXPHARMA 20-Nov-2019

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 21.11.2019 to 24.11.2019. Trading of the shares of the Company will remain suspended on record date i.e., 25.11.2019.

BXPHARMA 14-Nov-2019

(Q1 Un-audited): Consolidated EPS was Tk. 2.13 for July-September 2019 as against Tk. 1.86 for July-September 2018; Consolidated NOCFPS was Tk. 4.59 for July-September 2019 as against Tk. 1.05 for July-September 2018. NAV per share was Tk. 75.09 as on September 30, 2019 and Tk. 68.59 as on September 30, 2018.

BXPHARMA 05-Nov-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2019 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2019.

BXPHARMA 29-Oct-2019

There will be no price limit on the trading of the shares of the Company today (29.10.2019) following its corporate declaration.

BXPHARMA 29-Oct-2019

(Continuation news of BXPHARMA): The Company has also reported Consolidated EPS of Tk. 7.48, Consolidated NAV per share of Tk. 72.96 and Consolidated NOCFPS of Tk. 7.30 for the year ended on June 30, 2019 as against Tk. 6.25, Tk. 66.78 and Tk. 4.49 respectively for the same period of the previous year. (end)

BXPHARMA 29-Oct-2019

The Board of Directors has recommended 15% cash dividend for the year ended on June 30, 2019. Date of AGM: 21.12.2019, Time: 10:30 AM, Venue: Beximco Industrial Park, Sarabo, Kashimpur, Gazipur. Record Date: 25.11.2019. (cont.)

BXPHARMA 21-Oct-2019

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2019 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019.

Previous Next page